Syngene International recently launched its Centre for Advanced Protein Studies (CAPS) by the Secretary, Department of Biotechnology, Government of India. CAPSwas set up in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC) at Syngene’s campus in Bengaluru. The new centre will host a state-of-the-art GLP accredited analytical laboratory.
Kiran Mazumdar Shaw, Managing Director, Syngene, said, “In the last few years, India’s biotechnology sector has seen tremendous action. India has immense scientific and entrepreneurial talent available in the country that gives it strong potential to emerge as the R&D hub for the global biotechnology industry. The CAPS facility will provide the right ecosystem for this talent to pursue their research objectives.”
Jonathan Hunt, Chief Executive Officer, Syngene, said, “This collaboration will help Syngene play an active role in the development of India’s biotechnology industry as well as nurture the innovative spirit within the industry.”
Apart from providing the necessary infrastructure support at affordable cost, CAPS will also focus on involving advancing technical skill development to global standards, by conducting various trainings and workshops eminent subject experts.